The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

38 articles for EW Yue


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology.EBI
Incyte
Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.EBI
Incyte
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.EBI
Bristol-Myers Squibb
Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists.EBI
Bristol-Myers Squibb
Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines.EBI
Incyte
Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.EBI
Incyte
Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.EBI
Incyte
INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ).EBI
Incyte
NOVEL MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USEBDB
Temple University
HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOFBDB
Voronoi
COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THE SAMEBDB
University of Arizona
Substituted 4-phenylpiperidines, their preparation and useBDB
Columbia University
Immunomodulator compoundsBDB
Chemocentryx
Compound, compositions, and methodsBDB
Denali Therapeutics
Fused ring derivative having MGAT-2 inhibitory activityBDB
Shionogi
Substituted heterocyclyl derivatives as CDK inhibitorsBDB
Aurigene Discovery Technologies
Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptidesBDB
Arvinas Operations
Cyanoindazole compounds and uses thereofBDB
Incyte
IBAT inhibitors for the treatment of liver diseasesBDB
Albireo
Substituted indoles as modulators of ROR-gammaBDB
Vitae Pharmaceuticals
Benzimidazole derivatives as EP4 antagonistsBDB
Bayer Pharma Aktiengesellschaft
Kinetic and in silico analysis of thiazolidin-based inhibitors of a-carbonic anhydrase isoenzymes.BDB
Ondokuz Mayis University
Serine/threonine kinase inhibitorsBDB
Genetech
Hetarylcoumarins: Synthesis and biological evaluation as potent a-glucosidase inhibitors.BDB
Kinnaird College For Women
New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.BDB
Alexandria University
Antagonists of prostaglandin EP3 receptorBDB
Pfizer
Amino-substituted imidazopyridazinesBDB
Bayer Pharma Aktiengesellschaft
Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.BDB
Government College University
Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonistsBDB
Sanofi
Substituted isoquinolinones and quinazolinonesBDB
Novartis
Cyclohexane-1,2′-naphthalene-1′,2″-imidazol compounds and their use as BACE inhibitorsBDB
Astrazeneca
Oxadiazole inhibitors of leukotriene productionBDB
Boehringer Ingelheim International
Pharmacological characterization of KUR-1246, a selective uterine relaxant.BDB
Kissei Pharmaceutical
Design and synthesis of conformationally constrained cyclophilin inhibitors showing a cyclosporin-A phenotype in C. elegans.BDB
The University of Edinburgh
Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBDB
Bristol-Myers Squibb
 
DISCOVERY AND STRUCTURE-ACTIVITY STUDIES OF A NOVEL SERIES OF PYRIDO[2,3-d]PYRIMIDINE TYROSINE KINASE INHIBITORSBDB
Parke-Davis Pharmaceutical Research
Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug design.BDB
Sunesis Pharmaceuticals